Hereditary cancer syndromes are relatively rare, accounting for about 5% to 10% of all cancers. However, the impact is significant due to the high risk associated with these conditions. For instance, mutations in the BRCA1 and BRCA2 genes greatly increase the risk of breast and ovarian cancers.
